GNRH1 and metastatic prostate carcinoma: A recent study on 1566 metastatic prostate cancer patients treated with LHRH agonists showed that antiandrogen therapy before LHRH agonists was not associated with differences in fractures, spinal cord compression, bladder outlet obstruction, or narcotic prescriptions.